Neuropace
NPCE
NPCE
40 hedge funds and large institutions have $150M invested in Neuropace in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
44% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 16
Holders
40
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$6.32M | |
| 2 | +$2.8M | |
| 3 | +$2.5M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.47M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$599K |
Top Sellers
| 1 | -$5.65M | |
| 2 | -$3.59M | |
| 3 | -$2.35M | |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$1.94M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$192K |